RxDoctor Payments DataLook up a doctor →

Priya Mathur

Nurse Practitioner · Rock Hill, SCNPI 1124763669

Payments from drug & device makers

$12,105in general payments, 2019–2025

Across 472 payments — averaging $25.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Johnson & Johnson$948
  • AbbVie$728
  • AstraZeneca$701
  • Incyte Corporation$508
  • Taiho Oncology, Inc.$461
  • plus $7K from 54 others

What the payments were for

  • Consulting fees$2802%
  • Food & beverage$9,99983%
  • Education$4464%
  • Other$1,37911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis50$2,141
Johnson & Johnson36$948
AbbVie35$728
AstraZeneca(2 entities)22$701
Incyte Corporation18$508
Taiho Oncology, Inc.26$461
Pharmacosmos Therapeutics Inc.15$381
Genentech USA, Inc.20$372
Daiichi Sankyo Inc.14$342
Lilly USA, LLC15$314
Takeda Pharmaceuticals U.S.A., Inc.11$308
Sobi, Inc11$271
Adaptive Biotechnologies Corporation8$268
Merck9$252
Regeneron Healthcare Solutions, Inc.10$245
Pfizer11$237
Astellas Pharma US Inc7$215
E.r. Squibb & Sons, L.L.C.5$185
Array Biopharma Inc12$185
GSK8$170
Amgen8$167
Bristol Myers Squibb8$165
Stemline Therapeutics Inc.5$164
Eisai Inc.7$152
Servier Pharmaceuticals LLC6$137
Karyopharm Therapeutics Inc.6$124
Acrotech Biopharma Inc.5$116
Puma Biotechnology, Inc.6$106
CTI Biopharma Corp.5$104
Boehringer Ingelheim4$98
AVEO Pharmaceuticals, Inc.4$96
Tersera Therapeutics LLC3$91
Genmab U.S., Inc.4$80
G1 Therapeutics, Inc.4$79
Bayer3$77
Kyowa Kirin, Inc.4$71
Geron Corporation2$67
Exelixis Inc.3$67
Pharmacyclics LLC, An Abbvie Company3$63
Sandoz2$57
Seagen Inc.3$55
Sanofi2$55
ADC Therapeutics America, Inc.3$53
EUSA Pharma (US) LLC2$52
Legend Biotech USA Inc.1$48
Rigel Pharmaceuticals, Inc.2$46
Deciphera Pharmaceuticals Inc.2$42
Pharmaessentia USA Corporation2$40
CSL Behring1$37
Celltrion USA Inc.2$37
Sun Pharmaceutical Industries Inc.2$36
Beigene USA, Inc.2$33
Azurity Pharmaceuticals, Inc.1$31
Beone Medicines USA, Inc.1$28
Cycle Pharmaceuticals Inc1$26
Myriad Genetic Laboratories, Inc.2$26
Gilead1$23
Jazz Pharmaceuticals Inc.1$23
EMD Serono, Inc.1$21
Ipsen Biopharmaceuticals, Inc1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,105 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,775
Medicare patients
24
Services billed
85

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →